Avirmax's Chief Executive and Scientific Officer, Dr. Shengjiang Shawn Liu, Ph.D., will chair the upcoming session of "Acceleration of AAV Gene Therapy for Ocular Diseases: Improving Delivery and ...
Some results have been hidden because they may be inaccessible to you